275 related articles for article (PubMed ID: 18988302)
21. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.
Saw RP; Koorey D; Painter D; Gallagher PJ; Solomon MJ
Br J Surg; 2002 Nov; 89(11):1409-15. PubMed ID: 12390383
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
23. Association of K-ras mutations with liver metastases from colorectal carcinoma.
Tsunoda A; Iijima T; Tsunoda Y; Nakao K; Miyaki M; Kusano M
Anticancer Res; 2004; 24(4):2471-6. PubMed ID: 15330200
[TBL] [Abstract][Full Text] [Related]
24. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
27. Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study.
Boccia S; Persiani R; La Torre G; Rausei S; Arzani D; Gianfagna F; Romano-Spica V; D'Ugo D; Ricciardi G
Cancer Lett; 2005 Nov; 229(2):235-43. PubMed ID: 16137826
[TBL] [Abstract][Full Text] [Related]
28. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.
Csejtei A; Tibold A; Varga Z; Koltai K; Ember A; Orsos Z; Feher G; Horvath OP; Ember I; Kiss I
Anticancer Res; 2008; 28(3B):1917-22. PubMed ID: 18630481
[TBL] [Abstract][Full Text] [Related]
29. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
[TBL] [Abstract][Full Text] [Related]
30. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
31. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
[TBL] [Abstract][Full Text] [Related]
32. [Flow cytometric measurement of p53 protein and DNA content in colorectal carcinomas with liver metastasis].
Kimura O; Hisamitsu K; Sugamura K; Nakamura S; Kurayoshi K; Makino M; Kaibara N
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():134-9. PubMed ID: 7611776
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism of the p53 gene within the codon 72 in lung cancer patients.
Biros E; Kalina I; Biros I; Kohut A; Bogyiová E; Salagovic J; Stubna J
Neoplasma; 2001; 48(5):407-11. PubMed ID: 11845987
[TBL] [Abstract][Full Text] [Related]
34. Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
Molleví DG; Serrano T; Ginestà MM; Valls J; Torras J; Navarro M; Ramos E; Germà JR; Jaurrieta E; Moreno V; Figueras J; Capellà G; Villanueva A
Carcinogenesis; 2007 Jun; 28(6):1241-6. PubMed ID: 17259658
[TBL] [Abstract][Full Text] [Related]
35. p53 codon 72 polymorphism was associated with vulnerability, progression, but not prognosis of bladder cancer in a Taiwanese population: an implication of structural equation modeling to manage the risks of bladder cancer.
Lin HY; Huang CH; Yu TJ; Wu WJ; Yang MC; Lung FW
Urol Int; 2011; 86(3):355-60. PubMed ID: 21346315
[TBL] [Abstract][Full Text] [Related]
36. TGFbeta1 (Leu10Pro), p53 (Arg72Pro) can predict for increased risk for breast cancer in south Indian women and TGFbeta1 Pro (Leu10Pro) allele predicts response to neo-adjuvant chemo-radiotherapy.
Rajkumar T; Samson M; Rama R; Sridevi V; Mahji U; Swaminathan R; Nancy NK
Breast Cancer Res Treat; 2008 Nov; 112(1):81-7. PubMed ID: 18058229
[TBL] [Abstract][Full Text] [Related]
37. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
[TBL] [Abstract][Full Text] [Related]
38. Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients.
Laghi L; Bianchi P; Orbetegli O; Gennari L; Roncalli M; Malesci A
Br J Cancer; 2001 Jan; 84(2):196-8. PubMed ID: 11161376
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.
Koehler A; Bataille F; Schmid C; Ruemmele P; Waldeck A; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2004 Sep; 204(1):65-74. PubMed ID: 15307139
[TBL] [Abstract][Full Text] [Related]
40. [Association between vascular endothelial growth factor gene 936 T/C polymorphism and colorectal cancer together with anastomotic leakage].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1505-7. PubMed ID: 17349182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
